Downregulation of MYPT1 increases tumor resistance in ovarian cancer by targeting the Hippo pathway and increasing the stemness

Overview of attention for article published in Molecular Cancer, January 2020

Altmetric Badge

About this Attention Score

In the top 25% of all research outputs scored by Altmetric
High Attention Score compared to outputs of the same age (86th percentile)
High Attention Score compared to outputs of the same age and source (89th percentile)

So far, Altmetric has seen 15 X posts from 14 X users, with an upper bound of 24,661 followers.

RT @bmc_lab: We are proud to share our latest work on the role of MYPT1 in cancer stem cells and therapy resistance in ovarian cancer, led…

RT @bvsspa: 📘 Downregulation of MYPT1 increases tumor resistance in ovarian cancer by targeting the Hippo pathway and increasing the stemne…

📘 Downregulation of MYPT1 increases tumor resistance in ovarian cancer by targeting the Hippo pathway and increasing the stemness de @HospitalUVRocio @ibis_sevilla depositado en ⬇️⬇️⬇️ https://t.co/y49PtDQQFL #repositoriosalud #OA #ProduccionCientifica #SS

RT @bmc_lab: We are proud to share our latest work on the role of MYPT1 in cancer stem cells and therapy resistance in ovarian cancer, led…

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity, including 11 additional X posts.